Dong-Eun Chang Email & Phone Number

Daejeon, Daejeon, KR

Jung-gu, Seoul, KR

Jung-gu, Seoul, KR

• As the Chief Technology Officer and R&D Management Executive, I spearheaded the research and development (R&D) initiatives in strain engineering, fermentation, downstream processing (DSP), and application development.
• R&D Program Direction: Led comprehensive R&D programs for the development of commercially competitive production technology of biopolymers and biochemicals product lines based on PHA (Polyhydroxyalkanoates) platform.
• Scale-Up and Technology Transfer: Successfully managed the scale-up and technology transfer processes for the commercial production of two biopolymer products, ensuring efficient transition from laboratory to.
• Technical Guidance: Provided expert technical guidance throughout the establishment of pilot and commercial-scale manufacturing facilities for the production of bioproducts.
• Team Leadership: Built and managed a diverse R&D team of up to 110 professionals, including scientists, engineers, and technicians.
• Strategic Partnerships: Established and nurtured strategic partnerships with academic institutions and commercial research entities.

• In my role as Director of Research and Development, I successfully established and managed the R&D branch of a foreign company in the United States, focusing on advancing innovative biotechnologies and enhancing.
• R&D Branch Establishment: Spearheaded the setup and management of a new R&D center in the U.S., aligning our operations with corporate goals while fostering a collaborative and innovative work environment.
• Program Direction: Directed R&D programs specializing in strain and fermentation process development, with a strong emphasis on optimizing biopolymer production to improve efficiency and yield.
• Strategic Leadership: Led a dedicated R&D Strategy team responsible for exploring emerging biotechnologies within the biochemicals and biopharma sectors. This involved evaluating new technologies and executing.
• Collaborative Project Management: Managed collaborative projects focused on the process development for producing biologics, specifically targeting the use of outer membrane vesicles as vaccine candidates.
• Intellectual Property Oversight: Maintained and developed the intellectual property portfolio related to biopolymers, ensuring the protection of innovative technologies and maintaining a competitive edge in the.

Woburn, Massachusetts, US

• In my role as Director/Team Lead of the Microbial Research team, I led a dynamic group of 3 to 12 scientists and research associates focused on advancing microbial biotechnology to drive innovation in the bioplastics.
• Leadership and Team Management: Successfully managed and mentored a Microbial Research team, ensuring effective collaboration, resource allocation, and project prioritization to meet critical research and development.
• Strain Development for Commercial Production Spearheaded the development of robust microbial strains designed for the commercial-scale production of PHA biopolymers. These efforts were crucial in improving product.
• Metabolic Engineering Applied state-of-the-art molecular biology techniques to fine-tune microbial metabolism, driving strain performance beyond conventional benchmarks.
• Cross-Functional Collaboration Worked closely with application and commercial teams to establish clear product specifications, ensuring that the biopolymer products developed by the research team met both functional.
• Intellectual Property Contributed to the company’s intellectual property (IP) strategy by identifying key innovations and working with the legal team to secure patent positions.

Ann Arbor, Michigan, US

Synthetic Biology Construct biological circuits showing switch behavior or rhythmic gene expression for the development of developmental genetic switches in E. coli

Nashville, Tennessee, US

Circadian Rhythm Research on competitive advantages of circadian rhythm in cyanobacteria and halobacterium

Norman, Oklahoma, US

Systems Biology Developed an expanded stringent model during growth transition of E. coli with global gene expression profiling

Ph. D., Biotechnology

Bachelor'S Degree, Food Technology